Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands
W J Valentine, J Jendle, M Saraheimo, B Thorsteinsson, R F Pollock, M Lammert
Dyk ned i forskningsemnerne om 'Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands'. Sammen danner de et unikt fingeraftryk.